关于CGRP在同核素相关的神经退行性疾病中的潜在作用
Athanasia Alexoudi1, Vincenzo Donadio2, Elissaios Karageorgiou1
1Neurological Institute of Athens, Athens, Greece.
Frontiers in neuroscience
|November 21, 2024
概括
素基因相关 (CGRP) 可能与同核素相关的神经退行性疾病 (SAND) 有关. 针对CGRP途径可以为这些疾病提供新的治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 同核素相关的神经退行性疾病 (SAND) 是一组使人衰弱的疾病.
- 素基因相关 (CGRP) 在炎症,亡和脑肠沟通中起作用.
- 阿尔法同核素 (α-syn) 和CGRP都存在于中枢神经系统 (CNS) 和肠道神经系统 (ENS).
研究的目的:
- 探索CGRP和SAND之间的潜在临床病理学关联.
- 分析CGRP通路在神经退行性疾病发展中的作用.
- 假设针对SAND的CGRP的新型治疗策略.
主要方法:
- 文献综述和假设的制定.
- 对CNS和ENS中CGRP和α-syn的现有研究进行分析.
- 检查CGRP参与神经退行相关的关键生物过程的研究.
主要成果:
- 在关键的神经组织中,CGRP和α-syn并存.
- CGRP通路涉及诸如炎症和亡等过程,这些都是SAND的核心.
- 提出了CGRP失调和SAND病原体之间的潜在联系.
结论:
- 调节CGRP相关途径为开发SAND的疾病修饰疗法提供了一个有希望的途径.
- 需要进一步的研究来证实假设的关联.
- 这种假设可能为神经退行性疾病的创新治疗铺平道路.
相关概念视频
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K


